INSIGHTS ON CLINICAL TRIAL PARTNERING

CLINICAL TRIAL PARTNERING SOLUTIONS

  • Successfully navigating the complexities of bladder cancer research means mastering specialized delivery methods, managing supply constraints, and leveraging deep site relationships across all phases.

  • With three clinical pharmacology units, access to 145,000+ hepatic/renal patients, and 100+ completed studies, we’re your partner for NDA-enabling trials.

  • Accelerate study start-up with the right sites, patients, and partnerships

    As protocols become more complex and sites face new pressures, your site selection strategy needs to be more nuanced than ever before. At Parexel, we bring that nuance and precision with the help of our Site Alliance Strategists, Community Alliance Network and Launch Excellence Office — a team who are committed to launching your projects quickly and efficiently with expertise in all key functions in clinical development strategy, planning, oversight, and delivery execution.

  • ClinicReady is the surrogate for outsourced drug development team for preclinical biotechs.

  • Developing cutting-edge treatments for ovarian cancer requires specialized expertise and a people-first approach to research.